Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Clinical trial NCT02233049 · UNKNOWN
Trial details
- NCT number
- NCT02233049
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-10-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.